VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1817558
Sex: F
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: meniere's disease; dizziness; vertigo; This is a spontaneous report from a contactable other hcp (nurse). A 57-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection; batch or lot number was not reported) via an unspecified route of administration on an unspecified date (at the age of 57-years-old) as dose number unknown, single dose for covid-19 immunization. Patient received tofacitinib citrate (XELJANZ XR) tablet via orally from unspecified date in 2019 (Batch/Lot number was not reported; Expiration Date: 30Jan2023) to an unspecified date, at 11 mg, 1 daily for rheumatoid arthritis. The patient's medical history and concomitant medications were not reported. On unspecified date, the patient experienced dizziness, vertigo and Meniere's disease. Reporter stated behind one week on therapy (Xelianz XR) due to receiving covid vaccine. Patient reported currently being tested for vertigo and meniere's by ENT. The action taken for tofacitinib citrate was unknown. The outcome of the event dizziness was not recovered and for remaining events it was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the known safety profile of the vaccine BNT162B2, a temporal relation between the event Meniere's disease and the administration of the vaccine cannot be excluded.The impact of this report on the benefit/risk profile of the product is evaluated as part of procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: Xeljanz XR

Current Illness:

ID: 1817559
Sex: F
Age:
State: FL

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: The lymph nodes in my left armpit swelled and severely hurt.; The lymph nodes in my left armpit swelled and severely hurt.; My entire arm from my neck to my wrist swelled as well.; My entire arm from my neck to my wrist swelled as well.; The left side of my left breast is also swollen.; My arm is still very swollen and painful.; My entire arm from my neck to my wrist swelled as well.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 26Apr2021 at 13:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetic (type 1 diabetes mellitus), anxiety, depression and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), ubidecarenone (COQ), insulin human injection / isophane (HUMULIN N), insulin lispro (HUMALOG) and venlafaxine (MANUFACTURER UNKNOWN); all for an unknown indication from unknown date and unknown if ongoing. The patient previously took codeine (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 05Apr2021 at 13:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 27Apr2021 at 08:00, the patient's lymph nodes in left armpit swelled and severely hurt. Over the course of 2 days, the patient's entire arm from neck to wrist swelled as well. The left side of the left breast was also swollen. Over 5 days after the vaccine, the patient's arm was still very swollen and painful. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lymph nodes in left armpit swelled and severely hurt, entire arm from neck to wrist swelled as well, left side of the left breast was swollen breast is swollen, arm was very swollen and painful were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ROSUVASTATIN; HUMULIN N; HUMALOG; VENLAFAXINE; COQ

Current Illness:

ID: 1817560
Sex: F
Age:
State: IN

Vax Date: 03/25/2021
Onset Date:
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Leg swelling, legs from the knee down swell up really bad; Hard of hearing; This is a spontaneous report from a contactable consumer or other non hcp. A 71-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 25Mar2021 (Age at vaccination 71 years old) (Batch/Lot Number: EW6199) as DOSE 1, SINGLE for covid-19 immunisation, warfarin (WARFARIN), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history was not reported. Concomitant medication(s) included simvastatin (SIMVASTATIN) taken for an unspecified indication, start and stop date were not reported. Consumer sated, "she hard of hearing. Oh I had a reaction to both of the Pfizer shots, patient had her first on 25Mar2021 and the only thing that and she did not related to vaccination or the shot, she had leg swelling and it was about a week after she had the shot and both of her legs from the knee down swell up really bad and she just kind of passed it off with activity and all that and she went to her doctor and he put him on Lasix 40 mg on the 26th of April and went some blood work and it hasn't done anything (further clarification unknown) they are like, they look like logs. So, she have not got in touch with him but that started about a week after, she had nothing else, they are still swollen, there is no pain, they are just huge and like 'tree stuff'. Therapeutic measures were taken as a result of leg swelling, legs from the knee down swell up really bad (peripheral swelling). Outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: SIMVASTATIN, WARFARIN

Current Illness:

ID: 1817562
Sex: F
Age:
State: PA

Vax Date: 03/12/2021
Onset Date: 03/14/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: I am just frustrated with my pain; Fatigue; Nausea; Diarrhea; I am very sick and I had very bad last night because of nausea and diarrhea, it doesn't seem to stop or go away; It just did not stop; This is a spontaneous report from a contactable consumer. This 65-year-old female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6206) via an unspecified route of administration on 12Mar2021 (at 65-year-old) on left arm as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EP7533) via an unspecified route of administration on 01Apr2021 (at This 65-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 14Mar2021 patient was very sick and I had very bad last night because of nausea and diarrhea, it did not seem to stop or go away. She was sick every day and it just did not stop. It was because of both the shots or I should say, it never went away after the first shot and She said, she had an adverse event after she got both the Covid shots. She said she had fatigue. On an unknown date she was frustrated with her pain. Also, she said that she does have chronic health problem. Also, she contacted her doctor and they gave her couple of medications but her symptoms were still pretty bad. For treatment of events consumer stated, her medication was changed and it had not improved her situation, they changed the dose in it. One of the medication was Zonisamide, they increased the dosage hoping that it would improve the nausea but it did not. So, the medication that treat chronic health condition they were trying to treat to help me but it was not helping at all, it did not make any sense. The event outcome was unknown. There was a Product Complaint. Follow-up attempts were not needed. Further information was not expected.

Other Meds: ZONISAMIDE; DILTIAZEM; METOPROLOL.

Current Illness:

ID: 1817563
Sex: F
Age:
State: MA

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210410; Test Name: heartbeat; Result Unstructured Data: Test Result:increased

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: asthma crisis; cough; shortness of breath; heartbeat also increased significantly; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration, administered in right arm on 09Apr2021 at 15:00 (at the age of 46-years-old) as dose 1, single for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included asthmatic. There were no concomitant medications. The patient previously took quinolone and experienced drug allergy. On 10Apr2021 around 23 pm, patient suddenly got asthma. That made her cough, and she experienced a shortness of breath. The crisis got away by itself. Patient didn't take any medication. Her heartbeat also increased significantly but that usually the case when she has an asthma crisis. The events were resolved on an unspecified date in Apr2021.

Other Meds:

Current Illness:

ID: 1817564
Sex: F
Age:
State: NY

Vax Date: 05/02/2021
Onset Date: 05/02/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rash on forearms; Difficulty swallowing; Palpitations; This is a spontaneous report from a contactable healthcare professional (patient). This non-pregnant 51-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0179) via an unspecified route of administration in the left arm on 02May2021 at 08:15 (at 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date and unknown if ongoing; and known allergies to latex, sap, and birch fruits from unknown dates. Concomitant medications included venlafaxine hydrochloride (EFFEXOR) and valsartan, both from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EW0158) on 11Apr2021 at 08:15 (At 51-years-old) in the left arm for COVID-19 immunisation; and prochlorperazine (COMPAZINE) from an unknown date for an unknown indication and experienced allergy. The patient had not received any other vaccines in four weeks. On 02May2021 at 09:15 the patient experienced rash on forearms, difficulty swallowing and palpitations. The events resulted in an emergency department or urgent care visit. The patient was treated with a shot of prednisone and diphenhydramine hydrochloride (BENADRYL). The clinical outcome of the events was recovering. Since vaccination, the patient had not been tested for COVID-19.; Sender's Comments: Based on the information provided, the contributory role of the suspect product BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0179), to reported events rash, dysphagia and palpitations is possible. Case will be reassessed upon receipt of follow-up information.

Other Meds: EFFEXOR; VALSARTAN

Current Illness:

ID: 1817565
Sex: F
Age:
State: FL

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: This is a spontaneous report from a contactable nurse (patient). A 43-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0151), at the age of 43, via an unspecified route of administration, in the left arm, on Apr 30, 2021, at 10:15, single dose, for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6206), at the age of 43, via an unspecified route of administration, in the left arm, on Apr 9, 2021, at 16:00, single dose, for COVID-19 immunisation. The patient did not receive other vaccines within four weeks prior to the vaccination. On May 1, 2021, at 21:00, patient experienced sore arm, sore armpit, one episode of nausea, vomiting, generalized body aches, fatigue and tender enlarged supraclavicular lymph node. The events did not result in doctor or other healthcare professional office/clinic visit/emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of sore arm, sore armpit, one episode of nausea, vomiting, generalized body aches, fatigue and tender enlarged supraclavicular lymph node: resolving (at the time of this report). No follow-up attempts needed. No further information expected.

Other Meds:

Current Illness:

ID: 1817566
Sex: M
Age:
State: MI

Vax Date: 04/30/2021
Onset Date: 05/02/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Now there was pressure in "my" chest; Hard to breathe; "I" had slight muscle pain in "my" right arm.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 30Apr2021 at 10:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included pneumonia which the patient had when he was around six years old. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 04Apr2021 at 10:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. On 02May2021 at 23:00, the patient reported that after he finished cutting the grass and coming inside to have noodles for dinner, he experienced slight muscle pain in his right arm, went to bed for the night. After waking up today (as reported), there was still a slight muscle pain in his right arm. As the morning passed, the muscle pain in his right arm went away. However, on 03May2021, there was pressure in his chest and he found it hard to breathe. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle pain was recovered on 03May2021; while the outcome of the events pressure in my chest and find it hard to breathe were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1817567
Sex: M
Age:
State: WA

Vax Date: 04/28/2021
Onset Date: 04/29/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210429; Test Name: Heart rate; Result Unstructured Data: Test Result:110+ instead of 75 (unspecified units); Test Date: 20210429; Test Name: Body temperature; Result Unstructured Data: Test Result:101 (unspecified units)

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Chills; Fever; Elevated resting heart rate; Stomach ache; Partial constipation; Injection site soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 28Apr2021 at 16:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included stents due to prior heart attack. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); both from unknown start date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 07Apr2021 at 16:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 09:00, started next day to vaccination, the patient experienced chills, 101 fever, elevated resting heart rate (110+ instead of 75), stomach ache (due to partial constipation) and injection site soreness. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. On 29Apr2021, the patient underwent body temperature test and the result was 101 (unspecified units) and underwent heart rate test and the result was 110+ (unspecified units) instead of 75 (unspecified units). Therapeutic measures were taken as a result of fever and included treatment with 3 acetaminophen (MANUFACTURER UNKNOWN) 500 mg to manage fever from an unknown start date to an unknown stop date. The clinical outcome of the events chills, fever, elevated resting heart rate, stomach ache (due to partial constipation) and injection site soreness was resolved on 30Apr2021, after the duration of 1 day. No follow-up attempts are possible. No further information is expected.

Other Meds: ATORVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1817568
Sex: F
Age:
State: CT

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210501; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:Normal /95; Comments: At 22:30, Pulse ox normal /95; Test Date: 20210502; Test Name: Pulse rate; Result Unstructured Data: Test Result:120; Comments: At 07:00, Pulse 120; Test Date: 20210502; Test Name: Body temperature; Result Unstructured Data: Test Result:97.6; Comments: At 07:00, 97.60 temp

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Congested left side; Shakes; Pulse very high / Pulse 120; Arms legs feel like bricks attached; Stomach nauseous acid reflux; Stomach nauseous / Nausea; Feel like there's war inside body / Worst ever felt in life / feel like going 1000 mph; Fingertips to toes buzzing with this something inside; Tongue swollen; Cannot sleep, like a constant panic attack feeling; Cannot sleep, like a constant panic attack feeling; All muscles hurt; Fingers ice cold; Skin burning; Hot to touch; Exhausted; Bumpy rash started on arm (not at injection site); Initially felt dizzy for about 2 hours / Dizzy again; Pain in left arm where given up / sore arm continued; Pain in left arm where given up and into neck; Pins needles in left hand / Pins needles in feet; Both eyes dry ,burning, watery all day / Eyes burningdry / Burning watery, yet dry feeling; Both eyes dry, burning, watery all day / eyes burning / Burning watery, yet dry feeling; Both eyes dry, burning, watery all day / Burning watery, yet dry feeling; Excess saliva, spitting; Metal taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 11:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received cefaclor (CECLOR) and carbamazepine (TEGRETOL) and experienced drug allergy. On 01May2021, the patient initially felt dizzy for about 2 hours, pain in left arm where given up into neck and pins needles in left hand, all of which got better as the day went on; sore arm continued, both eyes dry, burning and watery all day; the patient acted normal, busy day; all day the patient had excess saliva, spitting and metal taste in mouth. On 01May2021 at 22:30, major effects started at night where the patient experienced shakes, pulse very high, arms legs felt like bricks attached and stomach nauseous acid reflux. The patient felt like there was war inside her body; fingertips to toes buzzing with that something was inside of her; eyes were burning and dry; tongue swollen, no headache, could not sleep, felt like a constant panic attack feeling and all muscles hurt. The patient felt dizzy again, fingers ice cold and skin burning hot to touch. There was no fever and pulse ox was normal /95. The patient reported that it was the worst she ever felt in her life; exhausted, but felt like she was going 1000 miles per hour (mph); pins needles in feet and bumpy rash started on arm (not at injection site). On 02May2021 at 07:00, the patient had 97.6 (unspecified units) temperature, pulse 120, congested left side, nausea and burning watery, yet dry feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 01May2021 at 22:30, the patient underwent oxygen saturation test and the result was normal /95. On 02May2021 at 07:00, the patient underwent body temperature test and the result was 97.6 (unspecified units) and on the same day, the patient underwent pulse rate test and the result was 120 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events initially felt dizzy for about 2 hours / dizzy again, pain in left arm where given up and into neck / sore arm continued, pins needles in left hand / pins needles in feet, both eyes dry, burning, watery all day / eyes burning dry / burning watery, yet dry feeling, excess saliva, spitting, metal taste in mouth, shakes, pulse very high / pulse 120, arms legs feel like bricks attached, stomach nauseous acid reflux / nausea, feel like there's war inside body / worst ever felt in life / feel like going 1000 mph, fingertips to toes buzzing with this something inside, tongue swollen, cannot sleep, like a constant panic attack feeling, all muscles hurt, fingers ice cold, skin burning, hot to touch, exhausted, bumpy rash started on arm (not at injection site) and congested left side was resolved on an unknown date in May2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1817569
Sex: F
Age:
State: IL

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: This is a spontaneous report from a contactable pharmacist. A 56-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 56, intramuscularly, on Apr 26, 2021, single dose, for COVID-19 immunisation. Medical history included lupus and asthma. It was unknown if the patient was pregnant at vaccination. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications not reported. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On Apr 26, 2021, patient had a very sore arm and fatigue. The events did not result in doctor or other healthcare professional office/clinic/emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of very sore arm and fatigue resolved on an unknown date in 2021. No follow-up attempts required. Information about batch/lot number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1817570
Sex: F
Age:
State:

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Headache; Fever; Throat soreness; Joint pain; Body aches; Body chills; Severe arm soreness; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. It was not reported if the patient had received any other vaccines within four weeks prior to the vaccination. On 25Apr2021, the patient experienced headache, fever, severe arm soreness, throat soreness, joint pain, body aches and body chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fever, severe arm soreness, throat soreness, joint pain, body aches and body chills were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1817571
Sex: F
Age:
State: VA

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: mouth on left side drooped some; my lips started to swell and tingle; my lips started to swell and tingle; the left side of my face, from my jaw to the eye went partially numb; This is a spontaneous report from a contactable consumer (patient).This 48-year-old female patient received dose 2 of BNT162B2 (lot number ER8736) via an unspecified route of administration on 30Apr2021 at 14:15 (at the age of 48-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies. The patient previously received dose 1 of BNT162B2 (lot number ER8731) on 09Apr2021 at 15:30 as a single dose in the left arm for COVID-19 immunization. Approximately 35 minutes after the dose was administered (also reported as 30Apr2021 at 14:45) the patient experienced lips started to swell and tingle and the left side of her face from her jaw to the eye went partially numb. Her my mouth on left side drooped some. It was similar to the sensation of numbness and drooping after receiving novacain at the dentist. The symptoms largely abated within one hour. The patient did not receive treatment for the events. The outcomes of lips started to swell and tingle, left side of her face went partially numb, and mouth on left side drooped some were recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1817572
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Just wanted to sleep; This is a solicited report based on the information received by Pfizer. (MFR Control No. # 21K-163-3876684-00). A non-contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), first dose via intramuscular on an unspecified 2021 as dose 1, single for COVID-19 immunisation; adalimumab (HUMIRA, Batch/Lot number was not reported), subcutaneous from 2016 to an unspecified date, at unspecified dose for psoriasis. There was no reported medical history. The patient's concomitant medications were not reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Social Media report by a consumer of a person with an event of non-serious Just wanted to sleep and drink water after first dose of Covid vaccine with Humira (adalimumab). On an unspecified date in 2021, the patient experienced Just wanted to sleep and drink water after first dose of Covid vaccine. Covid-19 vaccine was also considered suspect. Causality for Humira (adalimumab) and BNT162B2: The reporter's causality for the event of Just wanted to sleep and drink water after first dose of Covid vaccine was not provided. On unknown date in 2021, patient received 2nd dose COVID-19 Vaccine manufactured by Pfizer. The action taken in response to the event for adalimumab was unknown. The outcome of the event was reported as unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: HUMIRA

Current Illness:

ID: 1817573
Sex: F
Age:
State: VA

Vax Date: 04/30/2021
Onset Date: 05/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Rash/hives on right cheek, also near "my" mouth; Hives on right cheek and near "my" mouth and in labia of vagina; Rash in labia of vagina; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 30Apr2021 at 10:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included cetirizine hydrochloride (ZYRTEC), daily vitamin (unspecified), ibuprofen (MOTRIN) and duloxetine hydrochloride (CYMBALTA); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 10:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 01May2021 at 12:00, the patient experienced rash/ hives on right cheek, also near her mouth and in labia of vagina. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with prednisone (DELTASONE) and triamcinolone (KENALOG). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash/ hives on right cheek, also near mouth and in labia of vagina were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; MOTRIN [IBUPROFEN]; CYMBALTA.

Current Illness:

ID: 1817574
Sex: F
Age:
State: GA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Sore upper arm, to be expected/ arm feels weak and hurts while using.; Injection site still extremely sore; arm feels weak and hurts while using.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 26Mar2021 at 15:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known drug allergies. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included unspecified regularly prescribed medications. On 26Mar2021 at 15:00, the patient experienced sore upper arm, which patient had expected. However, injection site was still extremely sore, arm felt weak and hurt while using. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore upper arm injection site was still extremely sore, arm felt weak and hurt while using was not resolved at the time of report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 16Apr2021 at 15:00 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1817575
Sex: F
Age:
State: MA

Vax Date: 04/29/2021
Onset Date: 04/29/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Lymph sites in pain; Diarrhea; Headache; Heart racing; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the arm left on 29Apr2021 at 10:15 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included postural orthostatic tachycardia syndrome (POTS), autonomic malfunction, vasovagal syncope, sulfonamide allergy, calling family allergy, latex allergy and adhesive allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included esomeprazole sodium (NEXIUM), topiramate (MANUFACTURER UNKNOWN), pyridostigmine (MANUFACTURER UNKNOWN), levothyroxine sodium (TIROSINT) and bupropion hydrochloride (WELLBEN); all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received paracetamol; oxycodone hydrochloride (PERCOCET) on an unknown date and experienced drug allergy. On 29Apr2021 at 11:00 (day 1), the patient experienced diarrhea, headache, heart racing. On an unknown date in Apr2021 (Day 2-3), the patient experienced lymph sites in pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, headache, heart racing and lymph sites in pain was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NEXIUM [ESOMEPRAZOLE SODIUM]; TOPIRAMATE; PYRIDOSTIGMINE; TIROSINT; WELLBEN.

Current Illness:

ID: 1817576
Sex: F
Age:
State: CA

Vax Date: 04/15/2021
Onset Date: 04/27/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210426; Test Name: Quest; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Very heavy/longer menstrual cycle; Very heavy/longer menstrual cycle; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. Since the vaccination, the patient had been tested for COVID-19. On 26Apr2021, the patient underwent lab tests and procedures which included quest (via nasal swab) and tested negative. On 27Apr2021, the patient experienced very heavy/longer menstrual cycle. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. The clinical outcome of the events very heavy/longer menstrual cycle was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1817577
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Chills; Nausea; Extreme tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 12:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included pericardial aortic replacement (aortic valve replacement) on 08Sep2016 and aortic stenosis. The patient was born with one kidney (renal agenesis). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) and olmesartan (MANUFACTURER UNKNOWN); both for unknown indication from an unknown date and unknown if ongoing. The patient previously received sulfur (MANUFACTURER UNKNOWN) and chloroquine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Feb2021 at 09:30 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. On 26Feb2021, the patient had no fever and experienced chills, nausea and extreme tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, nausea and extreme tiredness was resolved on an unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ATORVASTATIN; OLMESARTAN.

Current Illness:

ID: 1817578
Sex: F
Age:
State: NJ

Vax Date: 03/30/2021
Onset Date: 04/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Swollen lymph nodes for about 12 days already; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 08:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included diabetes. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vitamins (unspecified products) for unknown indications. On 01Apr2021, the patient experienced swollen lymph nodes for about 12 days already. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not recovered at the time of this report. On 20Apr2021 at 08:30, the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm (at the age of 60-years-old) as single dose for COVID-19 immunization. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected. Amendment: This follow-up report is being submitted to amend previously reported information: patient details (name) was updated, and second dose of BNT162B2 was deleted as suspect dose.

Other Meds:

Current Illness:

ID: 1817579
Sex: F
Age:
State: OR

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Tingling in feet and toes within an hour of vaccine, lasting a couple hours, both doses.; This is a spontaneous report from a contactable pharmacist, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an intramuscular route of administration in the left arm on 30Apr2021 at 08:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The medical history included sjogren's, celiac, chronic kidney disease (CKD) stage III and allergic to sulfonamide and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The concomitant medications included vitamin d nos (VITAMIN D), curcuma longa rhizome (TURMERIC), probiotic (unspecified), grapeskin extract (unspecified), ubiquinol (MANUFACTURER UNKNOWN) and ascorbic acid (VITAMIIN C), all for unspecified indications from unknown dates and unknown if ongoing. The patient previously received thiomersal (THIMEROSAL) on unknown date and experienced allergy. On 30Apr2021 at 09:30,within an hour of vaccine, the patient experienced tingling in feet and toes which lasted a couple of hours on both doses. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in feet and toes was resolved on 30Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D [VITAMIN D NOS]; TURMERIC [CURCUMA LONGA RHIZOME]; UBIQUINOL; VIT C.

Current Illness:

ID: 1817580
Sex: F
Age:
State: CA

Vax Date: 04/11/2021
Onset Date: 04/12/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Severe left arm pain and swelling; Severe left arm pain and swelling, Severe leg and feet , stomach swelling; Stomach swelling; Severe migraines; Extreme blurry vision; Severe body and joint pain; Severe body and joint pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 11Apr2021 at 12:45 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included glaucoma, spinal injuries, high blood pressure, hypertension, medical doctors advised the patient not to get flu vaccine because patient's mother was paralyzed from Guillain barre syndrome (possibly from flu vaccine) and known allergies to latex and food allergies but they went away. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. On 12Apr2021 at 05:00, the patient experienced severe left arm pain and swelling severe leg and feet, stomach swelling, severe migraines, extreme blurry vision and severe body and joint pain. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe left arm pain and swelling, severe leg and feet, stomach swelling, severe migraines, extreme blurry vision and severe body and joint pain were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1817581
Sex: F
Age:
State: VA

Vax Date: 04/21/2021
Onset Date: 04/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: chills; fatigue; odd sensation (unsure if related) as if lips were sunburned. (They were not).; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0162) via an unspecified route of administration in the left arm on 21Apr2021 at 09:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have any relevant medical history and known allergies. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 15:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:45, 12 hours after vaccination, the patient experienced chills. On an unspecified date in Apr2021, the patient experienced fatigue. On an unspecified date in 2021, the patient experienced odd sensation (unsure if related) as if lips were sunburned. (They were not). Started after vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills was resolved on an unknown date in Apr2021, while that of fatigue was resolved on an unknown date in 2021, and unsure if related, odd sensation as if lips are sunburned. (They are not.) was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1817582
Sex: F
Age:
State: IL

Vax Date: 04/29/2021
Onset Date: 05/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Large rash at injection site; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 29Apr2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included magnesium (MANUFACTURER UNKNOWN), vitamin b complex (MANUFACTURER UNKNOWN), cyanocobalamin (VITAMIN B12) and calcium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0158) via an unspecified route of administration on right arm on 08Apr2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced a large rash at injection site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event large rash at injection site was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MAGNESIUM; B COMPLEX [VITAMIN B COMPLEX]; VITAMIN B12 [CYANOCOBALAMIN]; CALCIUM.

Current Illness:

ID: 1817583
Sex: F
Age:
State: WA

Vax Date: 04/18/2021
Onset Date: 04/29/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Period arrived out of cycle and was considerably heavier than usual.; Considerably heavier than usual.; Passed more (and larger) clots than usual and bled much more than usual. This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0161) via an unspecified route of administration in the left arm on 18Apr2021 at 14:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included endometriosis. The patient had known allergies to Ni (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), withania somnifera (ashwagandha) (MANUFACTURER UNKNOWN and omega 3 (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. On 29Apr2021 at 07:45, the patient experienced period arrived out of cycle and was considerably heavier than usual. Patient passed more (and larger) clots than usual and bled much more than usual. In a single day, she used more feminine products than in a usual cycle, and still bled through three times much. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events period arrived out of cycle and was considerably heavier than usual, passed more (and larger) clots than usual and bled much more than usual was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SERTRALINE; LEVOTHYROXINE; ASHWAGANDHA; OMEGA 3 [FISH OIL.]

Current Illness:

ID: 1817584
Sex: F
Age:
State: TX

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Nausea; Vomiting; Lost weight; Diarrhea 5-8 times a day; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 19Apr2021 at 14:15 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021, the patient experienced nausea, vomiting, lost weight and had one week of diarrhea 5-8 times a day. The patient was on day 12 at the time of report and still had nausea and vomiting, lost weight. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021 post vaccination, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the event had one week of diarrhea 5-8 times a day was resolved on an unknown date in Apr2021. The clinical outcome of the events nausea, vomiting and lost weight was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1817585
Sex: F
Age:
State: AZ

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Muscles kept cramping; Severe stomach cramping; I felt loopy and had trouble driving myself home; I felt loopy and had trouble driving myself home; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old, non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in Apr2021 at 11:30 in the left arm (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On an unknown date in Apr2021, at 19:00, immediately after second vaccination the patient felt loopy and had trouble driving home. The patient slept fine that night but the second night muscles kept cramping. The patient was awakened from sleep by severe stomach cramping that was not felt in years. The patient took an Advil and finally after an hour the terrible pain subsided. The next day the patient seemed fine but noticed since then, random muscle cramping. It's been about a week since the patient last had the cramping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events muscles cramping and stomach cramping which included ibuprofen (ADVIL). Therapeutic measures were not taken as a result of the events felt loopy and had trouble driving home. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of stomach kept cramping and severe stomach cramping were recovered on an unknown date in Apr2021; while that of the events felt loopy and had trouble driving home were unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1817586
Sex: F
Age:
State: IN

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Localized pain at injection site; Severe joint pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 04May2021 at 14:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Medical history was not reported. Concomitant medications taken within two weeks of vaccination included lisdexamfetamine mesilate (VYVANSE) for unknown indication from unknown date and unknown if ongoing. The patient previously took neomycin sulfate; polymyxin b sulfate; gramicidin (NEOSPORIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 21:00, the patient experienced localized pain at injection site and severe joint pain. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL) and ibuprofen (MANUFACTURER UNKNOWN). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events localized pain at injection site and severe joint pain was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE.

Current Illness:

ID: 1817587
Sex: F
Age:
State: OR

Vax Date: 05/02/2021
Onset Date: 05/02/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210503; Test Name: Body temperature; Result Unstructured Data: Test Result:99.5-99.9F; Comments: elevated temperature.

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: elevated temperature of 99.5-99.9F; dizzy; Headache; Nausea; Tasted oddly; Fuzzy head; She had a fuzzy head and light sensitivity; Difficulty counting and carrying out basic tasks; Eyes felt hot; eyes sore; ears also ached; ache in arm that received shot; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 02May2021 at 13:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation for COVID-19 immunisation. Medical history included suspected allergy (due to full body hives) to something in "normal" laundry detergent. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) (two occasions) and cannabis sativa (cannabis) (MANUFACTURER UNKNOWN) (once); both were from unknown date and for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158), via an unspecified route of administration in the left arm on 10Apr2021 at 13:00 (at the age of 33-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient woke during evening following second covid-19 vaccination with ache in arm that received shot. On 03May2021 at 01:00, the morning after the shot patient experienced a headache, nausea, and was unable to eat a whole banana because after biting it, it tasted oddly chemical and made her more nauseous. She had a fuzzy head and light sensitivity. She had difficulty counting and carrying out basic tasks. Her eyes felt hot and sore, and her ears also ached. Patient had some coffee and felt slight improvement but the headache stayed all day and into the evening. On the same day, the patient had an elevated temperature of 99.5-99.9 degrees Fahrenheit (normal for the patient using this thermometer is 96.4- 98.6 degrees Fahrenheit) until about 17:00. Mental clarity returned around 15:00. On 04May2021, the next day, she did not have a high temperature but was still nauseous with headache, dizzy at times as well. On 05May2021, the second day after vaccination, she had an extreme headache that worsened when she stood up or sit upright but went away completely if she laid down. Patient drank some salt supplemented water which reduced symptoms until evening. On 03May2021 at 17:00, the patient underwent body temperature and the result was 99.5-99.9 degrees Fahrenheit. Therapeutic measures were taken as a result of the events ache in arm, headache, nausea, tasted oddly chemical, fuzzy head, light sensitivity, eyes felt hot and sore, ears also ached and dizzy which included treatment with some coffee and drinking some salt supplemented water on 05May2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events ache in arm, headache, nausea, tasted oddly chemical, fuzzy head, light sensitivity, eyes felt hot and sore, ears also ached and dizzy was resolving at the time of this report. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event difficulty counting and carrying out basic tasks was resolved on 03May2021 while that of event elevated temperature of 99.5-99.9F was resolved on 04May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; CANNABIS.

Current Illness:

ID: 1817588
Sex: M
Age:
State: TX

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Fatigue/ tired; ran out of energy; lip tingling; Arm sore, left arm; This is a spontaneous report from a contactable consumer or other non-healthcare professional (patient) via medical information team. A 58-years-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0170), via an unspecified route of administration, administered in Arm Left on 23Apr2021 at 13:20 (age at the time of vaccination was 58 years) as dose 1, 0.3 ml single for covid-19 immunisation at a military hospital. Medical history included ongoing high blood pressure, ongoing high cholesterol (diagnosed many years ago, blood pressure was controlled now), ongoing chronic pain from 2014, allergy (allergy to shellfish and almonds) from an unknown date and unknown if ongoing and ongoing benign prostatic hyperplasia. He declined to report benign prostatic hyperplasia as a relevant medical condition for the report. Concomitant medications included lisinopril taken for high blood pressure from an unspecified start date (many years ago) and ongoing; atorvastatin calcium (LIPITOR) taken for high cholesterol which was controlled from an unspecified start date (many years ago) and ongoing; hydrocodone taken for pain from an unspecified start date (for 2 years) and ongoing; tadalafil (CIALIS) for benign prostatic hyperplasia from an unspecified start date (for 2 years) and ongoing; diphenhydramine hydrochloride (BENADRYL) taken for an unspecified indication, start and stop date were not reported, duloxetine hydrochloride (CYMBALTA) taken for an unspecified indication, start and stop date were not reported and seasonal allergy medications. The patient has not received any vaccination within 4 weeks prior to vaccination. No additional Vaccines were administered on same date of the Pfizer Suspect. On 23Apr2021, about 14.00, about 40 minutes after having first dose, the patient experienced lip tingling and arm sore, left arm in the evening. He reported that lip tingling lasted about 40 minutes and then went away. The event arm sore, left arm continued until the next day. The patient then reported that he experienced fatigue the next day. On 24Apr2021, at around 13.00, the patient experienced fatigue/flipped light switch and he ran out of energy, after the first vaccine. Caller states he was working outside at around 13.00 and it felt like a flipped light switch, and he ran out of energy. Caller stated that he stopped what he was doing and rested for 30-45 minutes. When he had to get out of bed, he was still tired, but felt alright. Caller stated the event lasted a couple of hours. He stated he was more concerned about getting his second dose of vaccine and if he could take a Benadryl beforehand. The adverse event did not require a visit to emergency room or physician office. Investigation Assessment was reported as no. The outcome of the event was lip tingling was recovered on 23Apr2021 at 14.40. The outcome of the event was Fatigue/ tired, ran out of energy and arm sore, left arm was recovered on 24Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; LIPITOR; HYDROCODONE; CIALIS; BENADRYL; CYMBALTA.

Current Illness: Benign prostatic hyperplasia; Chronic pain; High cholesterol (caller reports that he was diagnosed many years ago.); Hypertension (Caller stated he was diagnosed many years ago and reports that his blood pressure is controlled.)

ID: 1817589
Sex: M
Age:
State: MO

Vax Date: 05/01/2021
Onset Date: 05/02/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: leg cramps severe; mild chills; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 01May2021 at 16:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on 10Apr2021 at 12:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. On 02May2021, about 24 hours after 2nd shot, the patient experienced leg cramps which were severe and mild chills. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events leg cramps severe and mild chills were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1817590
Sex: F
Age: 82
State:

Vax Date: 02/20/2021
Onset Date: 10/19/2021
Rec V Date: 10/26/2021
Hospital: Y

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: breakthrough COVID-19 case

Other Meds:

Current Illness:

ID: 1817591
Sex: F
Age: 72
State: NC

Vax Date: 10/05/2021
Onset Date: 10/05/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: constipation (severe)-Severe, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Lymph Node Swelling-Mild, Systemic: Shakiness-Mild, Additional Details: patient presented with complaints of constipation that per patient increased in severitiy post vaccine and warrented an er trip. patient also stated she experienced shaking, muscle rigidity, headache, sob red raised skin areas and gait changes, patient went through vaers form which will be physically faxed to vaers.

Other Meds:

Current Illness:

ID: 1817592
Sex: F
Age: 70
State: NJ

Vax Date: 10/18/2021
Onset Date: 10/18/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817593
Sex: M
Age: 35
State: NJ

Vax Date: 10/18/2021
Onset Date: 10/18/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817594
Sex: M
Age: 36
State: TX

Vax Date: 10/21/2021
Onset Date: 10/21/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Additional Details: patient came back later in the afternoon in a cheerful mood to obtain COVID-19 card, say thank you, and that he was diagnosed with vasovagal syncope.

Other Meds:

Current Illness:

ID: 1817595
Sex: M
Age: 27
State: CA

Vax Date: 09/24/2021
Onset Date: 09/24/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817596
Sex: M
Age: 28
State: GA

Vax Date: 09/25/2021
Onset Date: 09/25/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817597
Sex: F
Age: 28
State: CA

Vax Date: 09/25/2021
Onset Date: 09/25/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817598
Sex: F
Age: 66
State: NY

Vax Date: 10/06/2021
Onset Date: 10/13/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Gluten,pcn, clindamycin, Lipitor, mastisol

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Loss of scalp hair, eyelashes

Other Meds: Coreg, nexium,nexus,, vit d2, multivitamin, turmeric, calcium w d, ginko Bilbao, cetirazine

Current Illness:

ID: 1817599
Sex: M
Age: 73
State: NJ

Vax Date: 10/18/2021
Onset Date: 10/18/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817600
Sex: F
Age: 40
State: NJ

Vax Date: 10/15/2021
Onset Date: 10/15/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817601
Sex: F
Age: 57
State: NJ

Vax Date: 10/15/2021
Onset Date: 10/15/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817602
Sex: M
Age: 31
State:

Vax Date: 10/25/2021
Onset Date: 10/26/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Received J&J in May. Took the moderna booster on 10/25. Woke up to chest pain that worsens with deep breaths

Other Meds:

Current Illness:

ID: 1817603
Sex: M
Age: 59
State: NJ

Vax Date: 10/15/2021
Onset Date: 10/15/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817604
Sex: M
Age: 41
State: NJ

Vax Date: 10/15/2021
Onset Date: 10/15/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817605
Sex: M
Age: 58
State: NY

Vax Date: 10/15/2021
Onset Date: 10/15/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Error: Improper Storage (temperature)-

Other Meds:

Current Illness:

ID: 1817606
Sex: M
Age: 37
State:

Vax Date: 10/25/2021
Onset Date: 10/25/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Client was given Pfizer vaccine as a booster dose. His first 2 Covid Vaccines were Moderna.

Other Meds:

Current Illness:

ID: 1817607
Sex: F
Age: 69
State: VA

Vax Date: 10/24/2021
Onset Date: 10/24/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Pt rec'd booster dose on 10/24/2021. Pt called into pharmacy on 10/25/2021 approx 11am complaining of large red, swollen, slightly hardened area extending from shoulder blade over the shoulder and down the arm all the way to the wrist (on the side on which the vaccine was given). Pt denied fever/chills. I advised pt to watch and wait, but also have primary care phycisain evaluate ( she has appt scheduled for 10/26/21.

Other Meds:

Current Illness:

ID: 1817608
Sex: M
Age: 37
State: MI

Vax Date: 10/25/2021
Onset Date: 10/25/2021
Rec V Date: 10/26/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: None

Allergies: None

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Lost consciousness and immediately felt flu symptoms since

Other Meds: None

Current Illness: None

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am